11 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... for Cryptococcal ... and Maintenance Therapy ... Recommendations for Cryptococcal ... Meningoencephalitis #IDSA
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
cavitation • Cryptococcus ... Leishmaniasis Differential ... patient has known cryptococcal ... for most OI • Cryptococcal ... Inflammatory #Syndrome #Differential
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... year B-III #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
in HIV / AIDS - Differential ... • IRIS might ... patients with IRIS ... lesions • CSF cryptococcal ... CNS #Infections #differential
Neurological Manifestations of Tuberculosis
Spinal Arachnoiditis & Polyradiculopathy:
 • Subacute onset of limb weakness, bladder/bowel dysfunction, muscle
Inflammatory Syndrome (IRIS ... antiretroviral therapy ... Tuberculosis #diagnosis #differential
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... and maintenance therapy ... Induction Therapy ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Aspergillus • Cryptococcus ... Marantic (NTBE) Differential ... antimicrobial therapy
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... those with KS-IRIS ... as adjunctive therapy ... KaposiSarcoma #Castlemans #IDSA
Endocarditis - Overview and Differential Diagnosis Framework

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV
- Overview and Differential ... Aspergillus • Cryptococcus ... antimicrobial therapy ... #Endocarditis #Differential